Volume 17, Number 10—October 2011
Dispatch
Outbreak of West Nile Virus Infection in Greece, 2010
Table 2
Characteristic | No. deaths, n = 33† | Case-fatality rate, % | Crude risk ratio (95% CI) | Adjusted risk ratio‡ (95% CI) |
---|---|---|---|---|
Age group, y | ||||
40–59 | 1§ | 2.50 | Reference | Reference |
60–69 | 2 | 6.90 | 2.76 (0.26–28.99) | 2.72 (0.26–28.40) |
70–79 | 15 | 17.65 | 7.06 (0.97–51.59) | 6.13 (0.83–45.17) |
>80 |
15 |
34.88 |
13.95 (1.93–100.9) |
11.41 (1.56–83.52) |
Sex | ||||
F | 10 | 11.36 | Reference | NA |
M |
23 |
21.10 |
1.86 (0.93–3.69) |
NA |
Underlying diseases | ||||
None | 2 | 3.92 | Reference | NA |
>1 |
31 |
21.23 |
5.41 (1.34–21.82) |
NA |
Hypertension | ||||
No | 19 | 15.70 | Reference | NA |
Yes |
14 |
18.42 |
1.17 (0.63–2.20) |
NA |
Heart disease | ||||
No | 18 | 12.00 | Reference | Reference |
Yes |
15 |
32.61 |
2.72 (1.49–4.95) |
2.03 (1.14–3.64) |
Diabetes | ||||
No | 23 | 15.44 | Reference | NA |
Yes |
10 |
20.83 |
1.35 (0.69–2.63) |
NA |
Immunosuppression | ||||
No | 31 | 17.42 | Reference | NA |
Yes |
2 |
10.53 |
0.60 (0.16–2.33) |
NA |
Cancer | ||||
No | 29 | 16.11 | Reference | NA |
Yes |
4 |
23.53 |
1.46 (0.58–3.66) |
NA |
Stroke | ||||
No | 28 | 15.30 | Reference | NA |
Yes |
5 |
35.71 |
2.33 (1.07–5.10) |
NA |
Renal failure | ||||
No | 31 | 16.40 | Reference | NA |
Yes | 2 | 25.00 | 1.52 (0.44–5.28) | NA |
*CI, confidence interval; NA, not applicable.
†Two additional patients with nonneuroinvasive disease died, and those deaths were not included in this analysis.
‡In logistic regression analysis, initial models included all variables for which the p value was <0.05 or the odds ratio was >1.1 or <0.90. Therefore, all variables were included in the initial models. Variables were removed 1 at a time depending on results of statistical testing (p<0.05), by using the likelihood-ratio test. All variables that remained significant in the final logistic regression model were included in the binomial regression model for the estimation of adjusted risk ratios.
§ Belonged to the 40–49-year age group.
Page created: September 26, 2011
Page updated: September 26, 2011
Page reviewed: September 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.